ProBioGen AG
Ellen Hilgenberg is a Business Development Manager at ProBioGen AG since September 2019, bringing extensive research experience from previous roles such as Postdoctoral Researcher at the Max Delbrück Center and PhD student at the Deutsches Rheumaforschungszentrum. Prior to these positions, Ellen served as a Graduate Research Associate at Charité, Institut für Pathologie, and as a Research Assistant at the Robert Koch Institut. Ellen holds a Diplom in Biology from Kiel University, completed in 2007.
ProBioGen AG
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines. Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon. With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.